Literature DB >> 31625024

Impact of margin status on long-term results of liver resection for hepatocellular carcinoma: single-center time-to-recurrence analysis.

Salvatore Gruttadauria1,2, Duilio Pagano3, Lidia R Corsini3,4, Davide Cintorino3, Sergio Li Petri3, Sergio Calamia3, Aurelio Seidita3, Fabrizio di Francesco3.   

Abstract

Occult metastasis from the initial tumor and a de novo second primary hepatocellular carcinoma (HCC) were recognized as the main causes for the onset of early and late HCC recurrence, after liver resection (LR). This study aims to compare the time to recurrence after LR for HCC in which a margin ≤ 1 mm or > 1 mm was achieved. A single-center retrospective study involving 256 patients was conducted from June 2005 to June 2019. HCC patients resected with a radical surgical approach were investigated and stratified into groups A (resection margins ≤ 1 mm) and B (> 1 mm), as measured on final pathologic assessment. Kaplan-Meier estimators were used to estimate the probability of recurrence, and the log-rank test was used to compare groups. Uni- and multivariable (stepwise) Cox regression models were used to assess the effect of several HCC pathological characteristics. Twenty patients were excluded for the presence of microscopic tumor invasion at pathologic analysis (R1); 236 patients underwent radical (R0) LR, and were included in the study and divided into group A (n = 61, 26%), and group B (n = 175, 74%). No differences between the two groups were detected regarding: epidemiology, tumor characteristics, type of LR, and follow-up. The estimated probability of recurrence for group A and group B at 12 and 24 months was 27% and 38%, and, 33% and 46%, respectively. Univariate and multivariable Cox regression model estimates showed that tumor grading (HR 2.1, 95% CI 1.2-3.4, p = 0.006), number of nodules (HR 1.2, 95% CI 1.0-1.4, p = 0.015), and extension of the resection (HR 1.8, 95% CI 1.0-1.1, p = 0.047) were independent risk factors for HCC recurrence, with no significant effect of margin status on time to recurrence. A R0 approach that considers a margin of resection > 1 mm does not improve the likelihood of HCC recurrence. Otherwise, our experience confirms that biologic tumor characteristics are the principal factors predictive of local and systemic recurrence.

Entities:  

Keywords:  Hepatocellular carcinoma; Liver resection; Liver transplantation; Margin status; Outcome

Year:  2019        PMID: 31625024     DOI: 10.1007/s13304-019-00686-5

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  4 in total

1.  Robotic liver resection for hepatocellular carcinoma: analysis of surgical margins and clinical outcomes from a western tertiary hepatobiliary center.

Authors:  Emanuel Shapera; Kaitlyn Crespo; Cameron Syblis; Sharona Ross; Alexander Rosemurgy; Iswanto Sucandy
Journal:  J Robot Surg       Date:  2022-10-21

2.  Clinical and Molecular-Based Approach in the Evaluation of Hepatocellular Carcinoma Recurrence after Radical Liver Resection.

Authors:  Salvatore Gruttadauria; Floriana Barbera; Pier Giulio Conaldi; Duilio Pagano; Rosa Liotta; Enrico Gringeri; Roberto Miraglia; Gaetano Burgio; Marco Barbara; Giada Pietrosi; Calogero Cammà; Fabrizio Di Francesco
Journal:  Cancers (Basel)       Date:  2021-01-29       Impact factor: 6.639

3.  How important is the role of iterative liver direct surgery in patients with hepatocellular carcinoma for a transplant center located in an area with a low rate of deceased donation?

Authors:  Duilio Pagano; Simone Khouzam; Bianca Magro; Marco Barbara; Davide Cintorino; Fabrizio di Francesco; Sergio Li Petri; Pasquale Bonsignore; Sergio Calamia; Giacomo Deiro; Calogero Cammà; Marco Canzonieri; Salvatore Gruttadauria
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738

4.  Bisegmentectomy 7-8 for Small-for-Size Remanant Liver for Cirrhotic Patients Under Right Hemi-hepatectomy With Hepatocellular Carcinoma: A Case-Matched Comparative Study.

Authors:  Xishu Wang; Yongrong Lei; Hongbo Huan; Shu Chen; Kuansheng Ma; Kai Feng; Wan Yee Lau; Feng Xia
Journal:  Front Surg       Date:  2021-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.